key: cord-0836640-6xcctafe authors: Darlenski, Razvigor; Tsankov, Nikolai title: Covid-19 pandemic and the skin - What should dermatologists know?()()() date: 2020-03-24 journal: Clin Dermatol DOI: 10.1016/j.clindermatol.2020.03.012 sha: ea4c7264c6851a3129b28a2253112a481a3f7209 doc_id: 836640 cord_uid: 6xcctafe The World has changed dramatically since the COVID-19 pandemic began. Together with our social, occupational, and personal life, the new corona virus poses novel challenges for all physicians, including dermatologists. Despite the virus not being dermatotropic, several skin conditions have emerged, mainly as a result of prolonged contact to personal protective equipment and excessive personal hygiene. Pressure injury, contact dermatitis, itch, pressure urticaria, and exacerbation of pre-existing skin diseases, including seborrheic dermatitis and acne, have been described. We have focused on the dermatologic aspects of COVID-19 infection, so that dermatologist may be aware of the skin complications and the preventive measures to be taken in the COVID-19 pandemic. In December 2019, a pneumonia of unknown cause was detected in Wuhan, China. It was later disclosed that the new (novel) type of corona virus causes respiratory disease spreading from person-to-person. The outbreak was declared a Public Health Emergency of International Concern on January 30, 2020, and on February 11, the World Health Association defined the new coronavirus disease as COVID-19 (1). Since then, the pandemic has spread to all continents except Antarctica. By mid-March 2020, there have been more than 200,000 cases reported worldwide. Whereas the time for reaching the first 100,000 cases took 12 weeks, only 12 days were needed to reach the next 100000 (1). In the United States, more than 10,000 cases and a total of 150 deaths from COVID-19 infection had been reported until March 21, 2020 (2). With the current global pandemic, dermatologists, like all physicians, should be aware of COVID-19 infection and any skin manifestations. The tropism of the virus for the structures of the bronchial mucosa and the immune system cells with typical histopathologic pattern has been demonstrated by using autopsy specimens from the lung, heart, kidney, spleen, bone marrow, liver, pancreas, stomach, intestine, thyroid, and skin (3) . Although the infection also involves changes of the heart, vasculature, liver, and kidney, the typical skin pattern was not initially described. Subsequently, mucosal membranes have been J o u r n a l P r e -p r o o f 7 closed doors. In addition, the scientific communication between dermatologists has been hindered with the cancellation of scientific meetings and academic sessions. A recent paper underlines the importance of patient triage at the entrance of a dermatology clinic and even the private office in order to regulate the clear vs. dirty flow (7) . Where possible, it may prove prudent to conduct outpatient visits with teledermatology or postpone such consultations for non-emergency patients and those with less skin ailments. Where appropriate, wearing a N95 mask (a PPE used to protect the face from airborne particles and liquids with very small dimensions of 0.3 micron) and hand hygiene are recommended during a patient visit (6) . The skin and COVID-19 interactions, as well as the consequences to the skin and mucous WHO. Coronavirus disease 2019 (COVID-19) A pathological report of three COVID-19 cases by minimally invasive autopsies Consensus of Chinese experts on protection of skin and mucous membrane barrier for healthcare workers fighting against coronavirus disease 2019 Emergency management for preventing and controlling nosocomial infection of 2019 novel coronavirus: implications for the dermatology department Dermatologic Manifestations of the 1918-1919 Influenza Pandemic Letter from the Editor: Occupational skin disease among healthcare workers during the Coronavirus (COVID-19) epidemic Adverse skin reactions to personal protective equipment against severe acute respiratory syndrome--a descriptive study in Singapore